Caissa Capital Management ltd. - Jun 12, 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
10%+ Owner
Signature
Cambyz Golestaneh, Title: Director
Stock symbol
AVTX
Transactions as of
Jun 12, 2023
Transactions value $
$63,629
Form type
4
Date filed
6/14/2023, 04:14 PM
Previous filing
Jun 9, 2023
Next filing
Jun 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $9.32K +2.15K +0.15% $4.34* 1.4M Jun 12, 2023 See Footnote (1) F1, F2
transaction AVTX Common Stock Purchase $33.4K +8.75K +0.62% $3.82* 1.41M Jun 13, 2023 See Footnote (1) F1, F3
transaction AVTX Common Stock Purchase $20.9K +6K +0.43% $3.48* 1.42M Jun 14, 2023 See Footnote (1) F1, F4
holding AVTX Common Stock 182K Jun 12, 2023 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.125 to $4.47, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7 to $3.83, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.245 to $3.55, inclusive.
F5 These shares are directly owned by Mr. Golestaneh in his personal capacity.